News and Updates

Leading researchers gathered, in person, for the annual meeting of the ATTD Conference (April 27-30), featuring 30+ studies presented by Breakthrough T1D scientists.

We're continuing that trend by putting the spotlight on video games and game developers with links to T1D.

Vertex provides an update on their Phase 1/2 Clinical Trial for VX-880, including data from three participants and details around the clinical hold.

Diabetes researchers from all over the world gather for the ATTD Conference, which will take place in-person and online from April 27-30 in Barcelona.

JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, has named two longtime, highly engaged volunteers to lead its International Board of Directors as Chair and Vice Chair, effective July 1, 2022.

You’ve seen the ads: Victoza®. Ozempic®. Trulicity®. But did you know that these drugs came about, in part, because of type 1 diabetes research?

Breakthrough T1D is grateful to Peggy Quirke, whose $3.2 million bequest will accelerate Breakthrough T1D's mission to find cures for type 1 diabetes (T1D).

In 1976, researchers set out to synthesize the human insulin gene and make human insulin, and Breakthrough T1D researchers had multiple hands in the biosynthesis of it.

In March 2022, Medicare beneficiaries became eligible for coverage for a greater number of CGMs than ever before. Due to a final rule issued on December 21, 2021 by the Centers for Medicare and Medicaid Services (CMS), any CGM that connects with an insulin pump or a standalone receiver will be covered by Medicare for […]

In conjunction with leading partners, Breakthrough T1D lends its support to Civica, to help combat a nationwide insulin affordability crisis.